Abstract

Implantation of biological corneal inlays, derived from small incision lenticule extraction, may be a feasible method for surgical management of refractive and corneal diseases. However, the refractive outcome is dependent on stromal remodelling of both the inlay and recipient stroma. This study aimed to investigate the refractive changes and tissue responses following implantation of 2.5-mm biological inlays with or without corneal collagen crosslinking (CXL) in a rabbit model. Prior to implantation, rotational rheometry demonstrated an almost two-fold increase in corneal stiffness after CXL. After implantation, haze gradually subsided in the CXL-treated inlays (p = 0.001), whereas the untreated inlays preserved their clarity (p = 0.75). In-vivo confocal microscopy revealed reduced keratocyte cell count at the interface of the CXL inlays at week 8. Following initial steepening, regression was observed in anterior mean curvature from week 1 to 12, being most prominent for the non-CXL subgroups (non-CXL: −12.3 ± 2.6D vs CXL: −2.3 ± 4.4D at 90 μm depth, p = 0.03; non-CXL: −12.4 ± 8.0D vs CXL: −5.0 ± 4.0D at 120 μm depth, p = 0.22). Immunohistochemical analysis revealed comparable tissue responses in CXL and untreated subgroups. Our findings suggest that CXL of biological inlays may reduce the time before refractive stabilization, but longer postoperative steroid treatment is necessary in order to reduce postoperative haze.

Details

Title
Corneal remodelling and topography following biological inlay implantation with combined crosslinking in a rabbit model
Author
Damgaard, Iben Bach 1 ; Yu-Chi, Liu 2 ; Riau Andri Kartasasmita 3 ; Teo Ericia Pei Wen 4 ; Li, Tey Min 5 ; Nyein Chan Lwin 4 ; Mehta, Jodhbir Singh 6 

 Aarhus University Hospital, Department of Ophthalmology, Aarhus, Denmark (GRID:grid.154185.c) (ISNI:0000 0004 0512 597X); Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670) 
 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-NUS Graduate Medical School, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924) 
 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Nanyang Technological University, School of Materials Science and Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361) 
 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670) 
 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Nanyang Technological University, School of Materials Science and Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361); Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-NUS Graduate Medical School, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2191355768
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.